The global GMP growth factor market is anticipated to grow at a significant CAGR during the forecast period (2022-2028).The GMP growth factor factor is growing owing to increasing demand for cell culture-based research in the field of wound management, oncology, cardiovascular, and other medical fields. The GMPgrowth factor also contributes to the use of stem cells in new therapeutic drugs. Hematopoietic stem cell therapy cytokines (growth factors) play a key role in regulating the many cellular parameters of hematopoietic stem including regeneration, silence, apoptosis, isolation, and mobilization.
Additionally, growth factors are also responsible for the cooperative of a few other growth factors with other hormone binding receptors in these cells. Hematopoietic stem cells are currently used to treat more than 80 medical diseases, including the immune system, blood disorders, metabolic disorders, genetic disorders, and several types of cancer, including leukemia and lymphoma.For instance, in December 2019, CEVEC and CellGenix announced the launch of GMP TGF-ß1 in the cell and genetic medicine industry. The introduction of such products is expected to boost the market growth of GMP cytokines during the forecast period.
Growth factors including epidermal growth factors, vascular epithelial growth factors, platelet-derived growth factors, and fibroblast growth factors play an important role in cancer research. In addition, the increasing demand for growth factors in regenerative medicine and the increase in research and development funding in the field of cancer research are increasing the need for growth factors across the globe.In July 2021, Abcam plc has opened a new US facility in Boston, MA Supporting rapid growth in R&D, production, and commercial operations with a new state-of-the-art 100,000 sqft facility.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global GMP Growth Factor Market at https://orionmarketreports.com/request-sample/?id=95101&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape-Abcam plc., Cell Signaling Technology Inc., General Electronics Co., Meridian Bioscience Inc., and Proteintech Group Inc., among others.
A full report is available at: https://orionmarketreports.com/global-gmp-growth-factor-market/95101/
Global GMP Growth Factor Market Report by Segment
By Type
- 25 mg
- 50 mg
- Others
By Application
- Cell/ Gene Therapy
- Tissue-Engineered Product
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
